SLCO1C1

Chr 12

solute carrier organic anion transporter family member 1C1

Also known as: OATP-F, OATP-RP5, OATP1, OATP14, OATP1C1, OATPF, OATPRP5, SLC21A14

The encoded protein is a transmembrane transporter that mediates sodium-independent uptake of thyroid hormones, particularly thyroxine (T4) and triiodothyronine, across the blood-brain barrier and into brain cells. Mutations cause autosomal recessive brain hypothyroidism with neurological defects, characterized by intellectual disability, movement disorders, and developmental delays despite normal systemic thyroid function. This gene is not highly constrained against loss-of-function variants (pLI near zero), consistent with recessive inheritance where heterozygous carriers are typically unaffected.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
7
Pubs (1 yr)
39
P/LP submissions
0%
P/LP missense
0.97
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLCO1C1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
39 unique Pathogenic / Likely Pathogenic· 83 VUS of 138 total submissions
📖
GeneReview available — SLCO1C1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.97LOEUF
pLI 0.000
Z-score 1.69
OE 0.69 (0.490.97)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.48Z-score
OE missense 1.07 (0.981.16)
392 obs / 366.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.69 (0.490.97)
00.351.4
Missense OE1.07 (0.981.16)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 23 / 33.5Missense obs/exp: 392 / 366.3Syn Z: -0.45
DN
0.77top 25%
GOF
0.7127th %ile
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

138 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic2
VUS83
Likely Benign5
Benign4
37
Pathogenic
2
Likely Pathogenic
83
VUS
5
Likely Benign
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
37
0
37
Likely Pathogenic
0
0
2
0
2
VUS
0
78
5
0
83
Likely Benign
0
4
1
0
5
Benign
0
2
1
1
4
Total084461131

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLCO1C1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →